IRIS

Endoscopic ultrasound (US)-guided radiofrequency ablation (RFA) has been investigated for pancreatic ductal adenocarcinoma (PDAC) but studies are limited and heterogeneous. Computed tomography (CT) scan features may predict RFA response after chemotherapy but their role is unexplored. The primary aim was to investigate the efficacy of ex-vivo application of a dedicated RFA system at three power on surgically resected PDAC in patients who underwent neoadjuvant chemotherapy. The secondary aim was to explore the association between pre-treatment CT-based quantitative features and RFA response.

Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy / Rossi, G., Petrone, M.C., Schiavo Lena, M., Albarello, L., Palumbo, D., Testoni, S.G.G., Archibugi, L., Tacelli, M., Zaccari, P., Vanella, G., Apadula, L., Crippa, S., Belfiori, G., Reni, M., Falconi, M., Doglioni, C., De Cobelli, F., Healey, A.J., Capurso, G., Arcidiacono, P.G.. - In: DEN OPEN. - ISSN 2692-4609. - 3:1(2023). [10.1002/deo2.152]

Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy

Palumbo, Diego;Testoni, Sabrina Gloria Giulia;Archibugi, Livia;Tacelli, Matteo;Vanella, Giuseppe;Crippa, Stefano;Belfiori, Giulio;Reni, Michele;Falconi, Massimo;Doglioni, Claudio;De Cobelli, Francesco;Capurso, Gabriele
Penultimo
;Arcidiacono, Paolo Giorgio
Ultimo
2023-01-01

Abstract

Endoscopic ultrasound (US)-guided radiofrequency ablation (RFA) has been investigated for pancreatic ductal adenocarcinoma (PDAC) but studies are limited and heterogeneous. Computed tomography (CT) scan features may predict RFA response after chemotherapy but their role is unexplored. The primary aim was to investigate the efficacy of ex-vivo application of a dedicated RFA system at three power on surgically resected PDAC in patients who underwent neoadjuvant chemotherapy. The secondary aim was to explore the association between pre-treatment CT-based quantitative features and RFA response.
2023
Inglese
DEN OPEN
John Wiley and Sons Inc
3
1
152
9
Pubblicato
2-s2.0-85159228471
WOS:001091438100029
35898840
https://onlinelibrary.wiley.com/doi/10.1002/deo2.152
Esperti anonimi
Sì
Internazionale
Goal 3: Good health and well-being
endoscopic ultrasound
ex‐vivo
neoadjuvant chemotherapy
pancreatic adenocarcinoma
radiofrequency ablation
Sì
Ex-vivo investigation of radiofrequency ablation in pancreatic adenocarcinoma after neoadjuvant chemotherapy / Rossi, G., Petrone, M.C., Schiavo Lena, M., Albarello, L., Palumbo, D., Testoni, S.G.G., Archibugi, L., Tacelli, M., Zaccari, P., Vanella, G., Apadula, L., Crippa, S., Belfiori, G., Reni, M., Falconi, M., Doglioni, C., De Cobelli, F., Healey, A.J., Capurso, G., Arcidiacono, P.G.. - In: DEN OPEN. - ISSN 2692-4609. - 3:1(2023). [10.1002/deo2.152]
open
20
info:eu-repo/semantics/article
262
Rossi, Gemma; Petrone, Maria Chiara; Schiavo Lena, Marco; Albarello, Luca; Palumbo, Diego; Testoni, Sabrina Gloria Giulia; Archibugi, Livia; Tacelli, ...espandi
1 Contributo su Rivista::1.1 Articolo in rivista
1.1 Articolo in rivista
File in questo prodotto:
File Dimensione Formato  
DEN Open - 2022.pdf

accesso aperto

Tipologia: PDF editoriale (versione pubblicata dall'editore)
Licenza: Creative commons
Dimensione 1.1 MB
Formato Adobe PDF
Visualizza/Apri
1.1 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/134904
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 4
  • ???jsp.display-item.citation.isi??? 4
social impact